MS Speaks

From the AARP (August 15, 2022), "How Medicare Rx Price Negotiations Will Work" (under the new law):


https://bit.ly/3pykmmg


If you look at the timetable in the article, this will be a long, slow process. The drug companies are being allowed plenty of time.


However, they will probably comply. There is a penalty for noncompliance, and it sounds pretty stiff:

Under the new law, if the maker of a drug that was selected for negotiation walks away from the table, the government could levy a tax of up to 95 percent of their sales from the previous year. The idea behind that tax is to give the pharmaceutical companies a strong incentive to participate in the negotiation process .